14T174: Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science (2527–2532)

Presenting Author(s)

• JC

  Jeffrey Curtis, MD, MS, MPH

  University of Alabama at Birmingham
  Hoover, AL, United States

  Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); CorEvitas: Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly and Company: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Myriad: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing)
• SK

  Sarah Keller, MD

  Cleveland Clinic Foundation
  Cleveland, OH, United States

  Disclosure information not submitted.
• MK

  Min Kim, PhD, MPH

  Amgen, Inc.
  Thousand Oaks

  Disclosure information not submitted.
• NM

  Nima Madanchi, MD

  Johns Hopkins University
  Baltimore, MD, United States

  Disclosure information not submitted.
• AP

  Andriko Palmowski, MD

  Charité - Universitätsmedizin Berlin
  Berlin, Germany

  Disclosure information not submitted.
• EW

  Edgar Wiebe, MD

  Charité University Medicine Berlin
  Berlin, Germany

  Disclosure information not submitted.

Abstract oral session.

Non-CME

Presentations:

• 4:00 PM - 4:10 PM PT

  Risk Factors for Bone Loss in Systemic Lupus Erythematosus
  

  Presenting Author: Nima Madanchi, MD – Johns Hopkins University
• 4:10 PM - 4:15 PM PT

  Q&A
  
• 4:15 PM - 4:25 PM PT

  Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-Fracture Treatment Among Commercially Insured Postmenopausal Women in the United States
  

  Presenting Author: Min Kim, PhD, MPH – Amgen, Inc.
• 4:25 PM - 4:30 PM PT

  Q&A
  
• 4:30 PM - 4:40 PM PT

  Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the U.S. Medicare Program
  

  Presenting Author: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
• 4:40 PM - 4:45 PM PT

  Q&A
  
• 4:45 PM - 4:55 PM PT

  Risk Evaluation of Osteoporotic Fractures Following Lung Transplantation (LT): A Retrospective Cohort Study Conducted at an International Transplant Center
  

  Presenting Author: Sarah Keller, MD – Cleveland Clinic Foundation
• 4:55 PM - 5:00 PM PT

  Q&A
  
• 5:00 PM - 5:10 PM PT

  Proton Pump Inhibitor Use Is Associated with Impaired Bone Mineral Density but Not Bone Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases Taking Glucocorticoids
  

  Presenting Author: Andriko Palmowski, MD – Charité - Universitätsmedizin Berlin
• 5:10 PM - 5:15 PM PT

  Q&A
  
• 5:15 PM - 5:25 PM PT

  Prevalence and Disease-Specific Factors Associated with Osteoporosis in Systemic Sclerosis: A Cross-Sectional Analysis of Two Large European Cohorts
  

  Presenting Author: Edgar Wiebe, MD – Charité University Medicine Berlin
• 5:25 PM - 5:30 PM PT

  Q&A